Organon of Oss, the Netherlands, and Entelos Inc. of Foster City, Calif., have announced a two-year extension of their research collaboration. Since 2001, the companies have worked to develop a large-scale mathematical model that simulates rheumatoid arthritis and the effects of current therapies and drugs in development.